Mendoza Family Fund Surpasses $1 Million in Partnership with the National Multiple Sclerosis Society
Milestone marks the culmination of years of grassroots fundraising inspired by the family’s matriarch Elsa Mendoza’s journey with MSNEW YORK,...
Milestone marks the culmination of years of grassroots fundraising inspired by the family’s matriarch Elsa Mendoza’s journey with MSNEW YORK,...
Together with P&G and CVS Pharmacy®, the campaign marks National Family Caregivers Month with expanded resources, promotional offers and a...
NORTHAMPTON, MA / ACCESS Newswire / October 29, 2026 / Strokes impact millions of lives yearly, with one in four...
INGELHEIM, DE / ACCESS Newswire / October 29, 2026 / Boehringer Ingelheim, today, on World Stroke Day, celebrates 10 years...
ExoCordOA, a five-year project, led by Exogenus Therapeutics and backed by Horizon Europe, brings together ten organisations spanning biotechnology, clinical...
Published in Nature Communications, the study found a 10-protein signature that outperformed a leading individual ALS biomarker, including in some...
The first intradiscal allograft to succeed in a rigorous, sham-controlled trial for chronic lumbar discogenic pain, a leading driver of...
The Comeback Club connects people who have had joint replacement with those considering it.ATLANTA and WARSAW, Ind., Oct. 26, 2026...
Malaysia and Indonesia, home to more than 310 million people with a fast-growing need for mental health care, form the...
U.S. Representatives Hoyer and Sessions Lead AbilityOne Modernization BillKidney Disease and Jobs are Focus of National Disability Employment MonthWASHINGTON, Oct....
Renovated space features new media production studio and enhanced facilities to advance the organization's mission nationwide ATLANTA, GA / ACCESS...
Privosegtor reduced post-onset increases in plasma neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) compared with placebo Lower...
Privosegtor reduced post-onset increases in plasma neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) compared with placebo Lower...
London, UK, 22 October 2026 - Persica Pharmaceuticals Limited (“Persica”), a clinical-stage biotechnology company developing PP353, a targeted, non-opioid treatment for...
Ad hoc announcement pursuant to Art. 53 LRBasel, 22 October 2026 Roche continues strong momentum in the third quarter with...
SALT LAKE CITY, Oct. 21, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal...
Tickets are now on sale for Man In Motion: The Rick Hansen Story at theatres from coast to coast -...
First disclosure of new imaging analyses and one-year functional outcome were presented at the World Stroke Congress todayChange in normalized...
DENVER, Oct. 19, 2026 /PRNewswire/ -- HapWare today announced that ALEYE has been named one of TIME's Best Inventions of 2026....
HOUSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive...